Re:Grow features clinically tested ch-OSA® (choline-stabilized orthosilicic acid) complemented with biotin. ch-OSA naturally helps nourish your body’s beauty proteins by supporting and activating enzymes used by collagen-generating cells to make collagen. Regular orthosilicic acid (OSA) has to be stabilized to avoid polymerization, a process that decreases bioavailability. ch-OSA’s patented choline-stabilization technology prevents polymers from forming and ensures OSA’s optimal absorption. By combining ch-OSA with biotin, Re-Grow offers an even greater level of beauty support.*

All Berman Sexual Health Formulas Meet or Exceed cGMP Quality Standards

Wheat, gluten, corn, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and preservatives.

1. Carlisle EM. Silicon as a trace nutrient. Sci Total Environ. 1988 Jul1;73(1-2):95-106. [PMID: 3212453]
2. Barel A, Calomme M, Timchenko A, et al. Effect of oral intake of choline-stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin. Arch Dermatol Res. 2005 Oct;297(4):147-153. [PMID: 16205932]
3. Wickett RR, Kossmann E, Barel A, et al. Effect of oral intake of choline-stabilized orthosilicic acid on hair tensile strength and morphology in women with fine hair. Arch Dermatol Res. 2007 Dec;299(10):499-505. [PMID: 17960402]
4. Spector TD, Calomme MR, Anderson SH, et al. Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial. BMC Musculoskelet Disord. 2008 Jun 11;9:85. [PMID: 18547426]
5. Viguet-Carrin S, Garnero P, Delmas PD. The role of collagen in bone strength. Osteoporos Int. 2006;17:319-336. [PMID: 16341622]
Shuster S. Osteoporosis, a unitary hypothesis of collagen loss in skin and bone. Med Hypotheses. 2005;65(3):426-432. [PMID: 15951132]
7. Calleja-Agius J, Muscat-Baron Y, Brincat MP. Skin ageing. Menopause Int. 2007 June;13(2):60-4. [PMID: 17540135]
8. Sumino H, Ichikawa S, Abe M, et al. (2004). Effects of aging and postmenopausal hypoestrogenism on skin elasticity and bone mineral density in Japanese women. Endocr J. 2004 Apr;51(2):159-164. [PMID: 15118265]
9. Calomme MR, Vanden Berghe DA. Supplementation of calves with stabilized orthosilicic acid. Effect on the Si, Ca, Mg, and P concentrations in serum and the collagen concentration in skin and cartilage. Biol Trace Elem Res. 1997 Feb;56(2):153-165. [PMID: 9164661]
10. Calomme MR, Wijnen P, Sindambiwe JB, et al. Effect of choline-stabilized orthosilicic acid on bone density in chicks. Calcif Tissue Int. 2002, 70:292. Poster presented at: 29th European Symposium on Calcified Tissues; May 25-29, 2002; Zagreb, Croatia. http://www.ectsoc.org/zagreb2002/poster3.htm. Abstract P-139. Accessed December 16, 2015.
11. Calomme MR, Geusens P, Demeester N, et al. Partial prevention of long-term femoral bone loss in aged ovariectomized rats supplemented with choline-stabilized orthosilicic acid. Calcif Tissue Int. 2006, Apr;78(4): 227-232. [PMID: 16604283]
12. Chan G. An open clinical study of the efficacy of choline-stabilized orthosilicic acid in the management of hair loss. A pilot study. Paper presented at: 17th Regional Conference of Dermatology; September 13-16, 2006; Bali, Indonesia.
13. Colombo VE, Gerber F, Bronhofer M, et al. Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopy. J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1127-32. [PMID: 2273113]
14. Hochman LG, Scher RK, Meyerson MS. Brittle nails: response to daily biotin supplementation. Cutis. 1993 Apr;51(4):303-5. [PMID: 8477615]
15. Scheinfeld N, Dahdah MJ, Scher R. Vitamins and minerals: their role in nail health and disease. J Drugs Dermatol. 2007 Aug;6(8):782-7. Review. [PMID: 17763607]
16. Floersheim GL. Treatment of brittle fingernails with biotin [in German]. Z Hautkr. 1989 Jan 15;64(1):41-8. [PMID: 2648686]
17. Sedel F, Bernard D, Mock DM, et al. Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis. Neuropharmacology. 2015 Sep 5. [Epub